Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine, discusses the interconnected condition of cardiovascular-kidney-metabolic (CKM) syndrome, which includes obesity, diabetes, chronic kidney disease, and cardiovascular disease.
Bispecific antibodies amivantamab and tarlatamab hold promise for patients.
National Action Alliance for Patient and Workforce Safety Webinar announcement
Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of…
Existing quality measures do not capture what is most important to individuals, particularly older adults with functional limitations and complex health issues. A new approach…
This series of webinars focuses on how to strengthen AHRQ’s primary research. For recordings of the presentations and slides, reference the webinars.
The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
This review focuses on the diagnostic accuracy of brief OCD assessment tools and the treatment of OCD in children. The 2012 American Academy of Child…
National Action Alliance for Patient and Workforce Safety Webinar announcement
.yellow { background-color: #FDB81E; color: #323A45; } .yellow:hover { background-color: #FFF1D2; color: #323A45; }
